125 related articles for article (PubMed ID: 6969422)
1. Blood lymphocyte functions in relation to splenic weight and tumor involvement in untreated Hodgkin's disease.
Björkholm M; Askergren J; Wedelin C; Holm G; Mellstedt H
Scand J Haematol; 1980 Jul; 25(1):51-7. PubMed ID: 6969422
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
Björkholm M; Holm G; Askergren J; Mellstedt H
Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
[TBL] [Abstract][Full Text] [Related]
3. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
Han T; Minowada J; Subramanian V; Barcos M; Kim U
Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytotoxic serum factors and lymphocyte functions in untreated Hodgkin's disease.
Björkholm M; Wedelin C; Holm G; Ericsson H; Nilsson P; Mellstedt H
Cancer; 1982 Nov; 50(10):2044-8. PubMed ID: 7127249
[TBL] [Abstract][Full Text] [Related]
5. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
6. Tissue T-lymphocytes in untreated Hodgkin's disease: morphologic and functional correlations in spleens and lymph nodes.
Baroni CD; Ruco L; Uccini S; Foschi A; Occhionero M; Marcorelli E
Cancer; 1982 Jul; 50(2):259-68. PubMed ID: 6979382
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.
Wedelin C; Björkholm M; Holm G; Ogenstad S; Johansson B; Mellstedt H
Br J Cancer; 1982 Jan; 45(1):70-9. PubMed ID: 6977367
[TBL] [Abstract][Full Text] [Related]
8. Computed tomography assessment of splenic size as a predictor of splenic weight and disease involvement in laparotomy staged Hodgkin's disease.
Hancock SL; Scidmore NS; Hopkins KL; Cox RS; Bergin CJ
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):93-9. PubMed ID: 8270463
[TBL] [Abstract][Full Text] [Related]
9. Letter: T lymphocytes and Reed-Sternberg cells in spleen of Hodgkin's disease.
Belpomme D; Joseph R; Navares L; Gerard-Marchant R; Huchet R; Botto I; Grandjon D; Mathé G
N Engl J Med; 1974 Dec; 291(26):1417. PubMed ID: 4547826
[No Abstract] [Full Text] [Related]
10. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of HL-A antigen phenotypes and lymphocyte abnormalities in Hodgkin's disease.
Björkholm M; Holm G; Johansson B; Mellstedt H; Möller E
Tissue Antigens; 1975 Oct; 6(4):247-56. PubMed ID: 1081776
[TBL] [Abstract][Full Text] [Related]
12. SPLEEN/PATHOL.
Bukowski RM; Noguchi S; Hewlett JS; Deodhar S
Am J Clin Pathol; 1976 Jan; 65(1):30-9. PubMed ID: 1082240
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous lymphocyte transformation in relation to the number of circulating lymphocytes in Hodgkin's disease.
de Mulder PH; de Pauw BE; Wagener DJ; Haanen C
Blut; 1981 Apr; 42(4):249-52. PubMed ID: 7225581
[TBL] [Abstract][Full Text] [Related]
14. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
Björkholm M; Holm G; Mellstedt H
Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
[TBL] [Abstract][Full Text] [Related]
15. Routine laboratory tests in relation to spleen size and tumour involvement in untreated Hodgkin's disease.
Wedelin C; Björkholm M; Holm G; Askergren J; Johansson B
Acta Med Scand; 1981; 209(4):309-13. PubMed ID: 7234507
[TBL] [Abstract][Full Text] [Related]
16. On the size and tumor involvement of the spleen in Hodgkin's disease.
Askergren J; Björkholm M; Holm G; Johansson B; Sundblad R
Acta Med Scand; 1981; 209(3):217-20. PubMed ID: 7223517
[TBL] [Abstract][Full Text] [Related]
17. The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease.
Stathopoulos G; Papamichail M; Peckham MJ; Davies AJ; Holborow EJ
Br J Exp Pathol; 1977 Dec; 58(6):712-6. PubMed ID: 305255
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte abnormalities in untreated patients with Hodgkin's disease.
Holm G; Mellstedt H; Björkholm M; Johansson B; Killander D; Sundblad R; Söderberg G
Cancer; 1976 Feb; 37(2):751-62. PubMed ID: 1082795
[TBL] [Abstract][Full Text] [Related]
19. Immunologic profile of patients with cured Hodgkin's disease.
Bjorkholm M; Holm G; Mellstedt H
Scand J Haematol; 1977 May; 18(5):361-8. PubMed ID: 141726
[TBL] [Abstract][Full Text] [Related]
20. Spleen involvement in Hodgkin's lymphoma: assessment and risk profile.
Rueffer U; Sieber M; Stemberg M; Gossmann A; Josting A; Koch T; Grotenhermen F; Diehl V;
Ann Hematol; 2003 Jul; 82(7):390-6. PubMed ID: 12764547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
